Biotech Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests
NewsDealsSocialBlogsVideosPodcasts
Compass Pathways Raises Undisclosed Amount After Trial Win
Undisclosed

Compass Pathways Raises Undisclosed Amount After Trial Win

•February 20, 2026
•Feb 20, 2026
0

Participants

Compass Pathways

Compass Pathways

company

Deal Summary

Compass Pathways, a pioneer in psilocybin-based therapies, announced a new fundraising round following a successful clinical trial. The fast raise, with terms undisclosed, will support further development and potential commercialization of its treatments.

0

Comments

Want to join the conversation?

Loading comments...